NEWS
Endpoints News | Sanofi inks an alliance pact with chronic disease-focused digital therapeutics player

Over the past few years, the digital health space has been rapidly expanding and drawing the attention of Big Pharma. Now, one company has grabbed Sanofi’s attention — and sealed a deal. New-York based DarioHealth announced it entered into a strategic alliance agreement with Sanofi’s US subsidiary in a multi-year, $30 million deal. The agreement […]

MedCity News | Sanofi and DarioHealth team up on digital health tools for chronic conditions

Under the agreement, the two companies will collaborate on promoting Dario’s digital offerings, which people can access via their smartphones. Dario uses artificial intelligence to personalize its offerings, engaging and supporting users with virtual care. The New York-based company’s first offerings were direct to consumer products developed for people who have diabetes. In 2020, Dario […]

Prader-Willi Syndrome News | Tonix, French Research Group Partner to Understand Oxytocin’s Potential in PWS

Tonix Pharmaceuticals has entered a research agreement with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm), to study the mechanisms behind the reported benefits of the oxytocin hormone in a mouse model of Prader-Willi syndrome (PWS). Inserm Transfert signed the deal on behalf of Inserm and the Aix-Marseille University in France — […]